Filtered By:
Condition: Alzheimer's
Cancer: Brain Cancers

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 221 results found since Jan 2013.

Hospital safety among neurologic patients: A population-based cohort study of adverse events
Conclusions: This study demonstrates that neurologic patients have a high proportion of AEs in hospital. The findings provide information on the quality and safety of care for people with neurologic conditions in hospital, which can help inform future quality improvement initiatives.
Source: Neurology - July 17, 2017 Category: Neurology Authors: Sauro, K. M., Quan, H., Sikdar, K. C., Faris, P., Jette, N. Tags: All Health Services Research, Medical care, All Clinical Neurology, Patient safety ARTICLE Source Type: research

Protective Effects of Spatholobi Caulis Extract on Neuronal Damage and Focal Ischemic Stroke/Reperfusion Injury
AbstractNeuronal apoptotic cell death plays an important role in many neurological disorders, including Alzheimer ’s disease, Parkinson’s disease, and ischemic stroke. Spatholobi Caulis (SC) has been widely used in traditional herbal medicine for the treatment of cancer, inflammation, viral infection, and anemia. However, the protective effects of SC extract (SCE) against apoptotic cell death in the brain h ave not been reported. We investigated the protective effects of SCE against neuronal injury etoposide-induced neurotoxicity and in rats subjected to focal transient ischemic stroke middle cerebral artery occlusion ...
Source: Molecular Neurobiology - July 13, 2017 Category: Neurology Source Type: research

Emerging Roles of Protein Kinases in Microglia-mediated Neuroinflammation.
Abstract Neuroinflammation is mediated by resident central nervous system glia, neurons, peripherally derived immune cells, blood-brain barrier, and inflammatory mediators secreted from these cells. Neuroinflammation has been implicated in stroke and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis. Protein kinases have been one of the most exploited therapeutic targets in the current pharmacological research, especially in studies on cancer and inflammation. To date, 32 small-molecule protein kinase inhibitors have been approved by ...
Source: Biochemical Pharmacology - July 3, 2017 Category: Drugs & Pharmacology Authors: Lee SH, Suk K Tags: Biochem Pharmacol Source Type: research

KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma.
This article will briefly review the available compounds (TRAM-34, senicapoc, NS6180), their binding sites and mechanisms of action, and then discuss the potential usefulness of these compounds for the treatment of brain tumors based on their brain penetration and their efficacy in reducing microglia activation in animal models of ischemic stroke and Alzheimer's disease. Senicapoc, which has previously been in Phase III clinical trials, would be available for repurposing, and could be used to quickly translate findings made with other KCa3.1 blocking tool compounds into clinical trials. PMID: 28676010 [PubMed - as supplied by publisher]
Source: Current Neuropharmacology - June 30, 2017 Category: Drugs & Pharmacology Authors: Brown BM, Pressley B, Wulff H Tags: Curr Neuropharmacol Source Type: research

Understanding Aphasia After Brain Injury
June is National Aphasia Awareness Month, and I wanted to share some of what I have learned on my journey through aphasia after brain injury. According to Wikipedia, the term aphasia implies that one or more communication modalities in the brain have been damaged—and are therefore functioning incorrectly. The difficulties for people with aphasia can range from occasional trouble finding words to losing the ability to speak, read, or write; their intelligence, however, is unaffected. Since no two brain injuries are ever the same, the way aphasia affects one person can vary greatly from the next person. In my own expe...
Source: Healthy Living - The Huffington Post - June 22, 2017 Category: Consumer Health News Source Type: news

Two older drugs could be 'repurposed' to fight dementia
Conclusion This early stage experimental research has demonstrated a beneficial neurological effect of trazodone and dibenzoylmethane on mice with diseases mimicking neurodegenerative diseases. It is important to acknowledge that this is animal research and therefore the drugs might not have the same effect when they are trialled on humans. That being said, trazodone is already an approved drug for depression and sleep problems and has therefore already passed safety tests. If the mechanisms of neurodegeneration in humans and mice are similar, it is possible trazodone could be used in the future in treating Alzheimer's and...
Source: NHS News Feed - April 20, 2017 Category: Consumer Health News Tags: Older people Neurology Medication Source Type: news

Novel quantitative imaging markers for understanding cognitive reserve in subdural hematoma (SDH) patients (P5.037)
Conclusions:Quantitative imaging can be used to predict functional outcomes in patients with intracranial hemorrhages. As we continue enrollment we hope to generate meaningful novel markers of cognitive reserve and recovery in patients with intracranial hemorrhages and other pathologies like acute stroke and brain tumors.Disclosure: Dr. Dangayach has nothing to disclose. Dr. Nicol has nothing to disclose. Dr. Sobotka has nothing to disclose. Dr. Griffiths has nothing to disclose. Dr. Costa has nothing to disclose. Dr. Lee has nothing to disclose. Dr. Mayer has received personal compensation for activities with Bard Medical...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Dangayach, N., Nicol, K., Sobotka, S., Griffiths, S., Costa, A., Lee, J., Mayer, S., Frontera, J., Gordon, E., Bederson, J. Tags: Neurocritical Care: Coma/Mental Status Source Type: research

Neurological Diseases Cost The U.S. $800 Billion Each Year
Over 100 million Americans ― close to a third of the total population ― suffer from neurological diseases such as Alzheimer’s, multiple sclerosis, migraines, epilepsy and spinal cord injury.  These conditions put an enormous financial strain on the health care system, totaling nearly $800 billion in annual costs, according to a new report published in the journal Annals of Neurology. To put that into perspective, the figure exceeds the U.S. military budget by over $100 billion.  That number reflects the total cost of the nine most common neurological diseases, but the total costs related to th...
Source: Healthy Living - The Huffington Post - March 30, 2017 Category: Consumer Health News Source Type: news

2017 Alzheimer's disease facts and figures
This article describes the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality rates, costs of care, and the overall impact on caregivers and society. The Special Report examines how the use of biomarkers may influence the AD diagnostic process and estimates of prevalence and incidence of the disease. An estimated 5.5 million Americans have Alzheimer's dementia. By mid-century, the number of people living with Alzheimer's dementia in the United States is projected to grow to 13.8 million, fueled in large part by the aging baby boom generation. Today, someone in the country develo...
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - March 14, 2017 Category: Geriatrics Source Type: research

Telomere Length, Long-Term Black Carbon Exposure, and Cognitive Function in a Cohort of Older Men: The VA Normative Aging Study
Conclusions: TL and CRP levels may help predict the impact of BC exposure on cognitive function in older men. Citation: Colicino E, Wilson A, Frisardi MC, Prada D, Power MC, Hoxha M, Dioni L, Spiro A III, Vokonas PS, Weisskopf MG, Schwartz JD, Baccarelli AA. 2017. Telomere length, long-term black carbon exposure, and cognitive function in a cohort of older men: the VA Normative Aging Study. Environ Health Perspect 125:76–81; http://dx.doi.org/10.1289/EHP241 Address correspondence to E. Colicino, Department of Environmental Health, Harvard T.H. Chan School of Public Health, 665 Huntington Ave., Building 1, Room G03, Bos...
Source: EHP Research - January 2, 2017 Category: Environmental Health Authors: Web Admin Tags: Research Articles January 2017 Source Type: research

The pain of chronic loneliness can be detrimental to your health
The changes came so gradually that, for a long time, Paula Dutton didn ’t realize she was in trouble. This was just modern life, after all — the cross-country distance from her close-knit family in Philadelphia, the end of a 10-year marriage, the death of one parent and then the other. By the time Dutton retired from her job, she was lonely to a degree that shocked and frightened her.“I just suddenly realized I was all alone and had no one around me and no one I could turn to,” says Dutton, now 71. “I had a lot of pity parties, I can tell you — and with all kinds of anxiety and depression. And I worked myself i...
Source: UCLA Newsroom: Health Sciences - December 22, 2016 Category: Universities & Medical Training Source Type: news

Direct Conversion of Somatic Cells into Induced Neurons
AbstractThe progressive loss and degeneration of neurons in the central nervous system (CNS), as a result of traumas or diseases including Alzheimer ’s, Parkinson’s, Huntington’s disease, stroke, and traumatic injury to the brain and spinal cord, can usually have devastating effects on quality of life. The current strategies available for treatments are described including drug delivery, surgery, electrical stimulation, and cell-based tiss ue engineering approaches. However, apart from cell-based therapy, other attempts are limited in improving clinical outcomes. Recently, stem cell and neural stem cell (NSC) in part...
Source: Molecular Neurobiology - December 15, 2016 Category: Neurology Source Type: research

Cigarette smoke and related risk factors in neurological disorders: An update.
Abstract Cigarette smoking is known to be harmful to health, and is considered the main cause of death worldwide, especially in India. Among the well-distinguished diseases related to smoking are, chronic obstructive pulmonary disease, oral and peripheral cancers, and cardiovascular complications. However, the impact of cigarette smoking on neurocognitive and neuropathological effects, including anxiety, Alzheimer's disease, Parkinson's disease, ischemic stroke, and blood-brain barrier dysfunction, still remains unclear. Cigarette smoke consists of more than 4500 toxic chemicals that combine to form free radicals,...
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - December 4, 2016 Category: Drugs & Pharmacology Authors: G SB, Choi S, Krishnan J, K R Tags: Biomed Pharmacother Source Type: research

Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection.
Abstract The neuroimmune system represents a dense network of biochemical signals associated with neurotransmitters, neuropeptides, neurohormones, cytokines, chemokines, and growth factors synthesized in neurons, glial cells and immune cells, to maintain systemic homeostasis. Endogenous and/or exogenous, noxious stimuli in any tissue are captured by sensor cells to inform the brain; likewise, signals originating at the central nervous system (CNS) level are transmitted to peripheral immune effectors which react to central stimuli. This multidirectional information system makes it possible for the CNS to respond to...
Source: Epilepsy Curr - November 1, 2016 Category: Neurology Authors: Cacabelos R, Torrellas C, Fernández-Novoa L, Aliev G Tags: Curr Pharm Des Source Type: research

Chapter Three Application of Nanomedicine to the CNS Diseases
Publication date: 2016 Source:International Review of Neurobiology, Volume 130 Author(s): D. Carradori, A. Gaudin, D. Brambilla, K. Andrieux Drug delivery to the brain is a challenge because of the many mechanisms that protect the brain from the entry of foreign substances. Numerous molecules which could be active against brain disorders are not clinically useful due to the presence of the blood–brain barrier. Nanoparticles can be used to deliver these drugs to the brain. Encapsulation within colloidal systems can allow the passage of nontransportable drugs across this barrier by masking their physicochemical properties...
Source: International Review of Neurobiology - September 24, 2016 Category: Neuroscience Source Type: research